Adrenal Cortical Adenoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Alzheimer's Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The findings lend weight to the premise that specific channels, such as MiRP2-Kv3.4, could hold promise as future therapeutic targets in Alzheimer's disease and potentially other neurodegenerative disorders.
|
17595326 |
2007 |
Atrial Fibrillation
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
Mutation screening of the KCNQ1, KCNE1, KCNE2, and KCNE3 genes was performed in 50 families with AF.
|
17276182 |
2007 |
Atrial Fibrillation
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
For example, phospholamban, the beta-subunit MinK (KCNE1) and MIRP2 (KCNE3), and the 2-pore potassium channel TWIK-1 were upregulated in AF-VHD compared with SR-VHD, whereas the T-type calcium-channel Cav3.1 and the transient-outward potassium channel Kv4.3 were downregulated.
|
16027256 |
2005 |
Atrial Fibrillation
|
0.040 |
Biomarker
|
disease |
BEFREE |
We aimed to investigate if mutations in potassium-channel β-subunits KCNE2 and KCNE3 are associated with early-onset lone AF.
|
24796621 |
2014 |
Atrial Fibrillation
|
0.040 |
Biomarker
|
disease |
LHGDN |
We suggest abnormalities in the KCNE3 gene as a potential genetic risk factor for initiation and/or maintenance of AF.
|
18209471 |
2008 |
Atrial Fibrillation
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
We suggest abnormalities in the KCNE3 gene as a potential genetic risk factor for initiation and/or maintenance of AF.
|
18209471 |
2008 |
AV Block First Degree by ECG Finding
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks).
|
15698834 |
2005 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
These results provide definitive evidence for a functional role of KCNE3 in the modulation of I(to) in the human heart and suggest that mutations in KCNE3 can underlie the development of BrS.
|
19122847 |
2008 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
CLINGEN |
Forty consecutive patients with Brugada-pattern electrocardiogram (ECG) underwent comprehensive genetic analysis of BrS-causing genes including SCN5A, SCN1B, SCN3B, CACNA1C, CACNB2, KCNE3 and KCNE5.
|
22987075 |
2012 |
Brugada Syndrome (disorder)
|
0.510 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
|
19306396 |
2009 |
Brugada Syndrome (disorder)
|
0.510 |
GeneticVariation
|
disease |
BEFREE |
These results provide definitive evidence for a functional role of KCNE3 in the modulation of I(to) in the human heart and suggest that mutations in KCNE3 can underlie the development of BrS.
|
19122847 |
2008 |
Brugada Syndrome 6
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Brugada Syndrome 6
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Genetics of Brugada syndrome.
|
27761167 |
2016 |
Brugada Syndrome 6
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Brugada Syndrome 6
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
KCNE3 T4A as the genetic basis of Brugada-pattern electrocardiogram.
|
22987075 |
2012 |
Brugada Syndrome 6
|
0.600 |
GeneticVariation
|
disease |
CLINVAR |
Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
|
19306396 |
2009 |
Brugada Syndrome 6
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Short QT syndrome.
|
16301704 |
2005 |
Cardiac Arrest
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiac Arrhythmia
|
0.020 |
GeneticVariation
|
phenotype |
BEFREE |
Inherited sequence variants in human KCNE1 and KCNE3 cause cardiac arrhythmias but by different mechanisms, and each is important for hearing in unique ways.
|
26410412 |
2016 |
Cardiac Arrhythmia
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Based on quantitative modeling of a transmural cardiac segment, we demonstrate that the degree of QT interval abbreviation observed results from electrotonic interactions in the face of limited transduction efficiency and that heterogeneous transduction of E3 may actually potentiate arrhythmias.
|
11956246 |
2002 |
Channelopathies
|
0.010 |
Biomarker
|
disease |
BEFREE |
Missense mutations in kcne1, kcne2, and kcne3 are linked to congenital and acquired channelopathies in Homo sapiens.
|
17491013 |
2007 |
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Episodic flaccid weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|